The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
Breast cancer stem cells (BCSC) play critical roles in the acquisition of resistance to endocrine therapy in estrogen receptor (ER)-positive (ER + ve) breast cancer (BC). The resistance results from complex alterations involving ER, growth factor receptors, NOTCH, Wnt/β-catenin, hedgehog, Y...
Main Authors: | David Rodriguez, Marc Ramkairsingh, Xiaozeng Lin, Anil Kapoor, Pierre Major, Damu Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/7/1028 |
Similar Items
-
ECM1 is associated with endocrine resistance in ER+ breast cancers
by: Tae Won Lee, et al.
Published: (2022-05-01) -
Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers
by: Linda A. Schuler, et al.
Published: (2021-07-01) -
ADJUVANT HORMONE THERAPY ELIGIBILITY OF PREMENOPAUSAL WOMEN WITH ER+ BREAST CANCER
by: V. F. SEMIGLAZOV, et al.
Published: (2017-06-01) -
Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
by: Tomás Reinert, et al.
Published: (2022-11-01) -
Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling
by: Thu Ha Pham, et al.
Published: (2021-01-01)